IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 33.426

Change

-0.05 (-0.14)%

Market Cap

N/A

Volume

700.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.03 (+0.16%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.30 (+0.51%)

USD 38.71B
DFAC Dimensional U.S. Core Equity 2..

+0.18 (+0.51%)

USD 33.57B
SGOV iShares® 0-3 Month Treasury B..

+0.02 (+0.02%)

USD 32.29B
JPST JPMorgan Ultra-Short Income ET..

+0.02 (+0.04%)

USD 28.80B
DTB DTE Energy Company 2020 Series

+0.11 (+0.59%)

USD 26.58B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 19.74B
GBTC Grayscale Bitcoin Trust (BTC)

+1.24 (+1.63%)

USD 19.50B
AVUV Avantis® U.S. Small Cap Value..

+0.32 (+0.33%)

USD 16.10B
CGDV Capital Group Dividend Value E..

+0.22 (+0.60%)

USD 13.61B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.97% 58% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.97% 58% F 55% F
Trailing 12 Months  
Capital Gain 8.73% 55% F 57% F
Dividend Return 0.86% 14% F 12% F
Total Return 9.59% 51% F 50% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.26% 76% C+ 58% F
Dividend Return 7.66% 75% C 52% F
Total Return 0.40% 24% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 9.35% 53% F 80% B-
Risk Adjusted Return 81.87% 84% B 88% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.